| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,232,310 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,232,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,369 |
77,189 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$12,356 |
D/D |
(929) |
81,718 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,115 |
82,647 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-24 |
4 |
D |
$13.08 |
$93,666 |
D/D |
(7,161) |
93,582 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-27 |
4 |
D |
$13.30 |
$31,854 |
D/D |
(2,395) |
97,556 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,919 |
98,637 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,369 |
99,951 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,106 |
100,743 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-28 |
4 |
D |
$13.10 |
$27,838 |
D/D |
(2,125) |
101,083 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,652 |
103,208 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$82,826 |
D/D |
(6,251) |
112,456 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-16 |
4 |
D |
$14.98 |
$13,871 |
D/D |
(926) |
113,645 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,115 |
114,571 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,525 |
118,707 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-23 |
4 |
D |
$16.31 |
$116,633 |
D/D |
(7,151) |
125,363 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$16,720 |
D/D |
(1,006) |
127,032 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,675 |
128,038 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-27 |
4 |
D |
$16.90 |
$40,476 |
D/D |
(2,395) |
131,007 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,869 |
132,514 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,370 |
133,402 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$35,913 |
D/D |
(2,125) |
134,534 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-05-29 |
4 |
S |
$18.52 |
$1,325,283 |
D/D |
(71,558) |
134,534 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,652 |
136,659 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-01-01 |
4 |
D |
$18.44 |
$125,337 |
D/D |
(6,797) |
146,778 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,150 |
153,575 |
0 |
- |
|
176 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
